NMPA Approval

Recombinant Human Brain Natriuretic Peptide for Injection

Approval Number

国药准字S20050033

Company成都诺迪康生物制药有限公司

Registration Date

July 13, 2020

Drug Information

Generic Name

注射用重组人脑利钠肽

Trade Name

新活素

Brand Name

新活素

Dosage Form

注射剂

Strength

0.5mg/ 500U/瓶

Drug Type

生物制品

Registration Date

July 13, 2020

Company Information

Applicant Company

Company Name成都诺迪康生物制药有限公司

Company Address

成都锦江工业开发区

Manufacturing Company

Company Name成都诺迪康生物制药有限公司

Company Address

成都锦江工业开发区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用重组人脑利钠肽 - NMPA 批准文号 | MedPath